DRW Securities’s Mentari Therapeutics, Inc. Common Stock MTRI Stock Holding History
Bought
Maintained
Sold
Other funds holding MTRI
SM
DRW Securities's MTRI Position: Q4 2025 in Review
DRW Securities sold out of Mentari Therapeutics, Inc. Common Stock (MTRI) in Q4 2025, closing a stake of 3,587 shares — an estimated $78.5K sold.
DRW Securities first reported a position in MTRI in Q3 2025 and held it in 1 quarter. The position peaked at $78.5K in Q3 2025. 6 funds tracked by Wall St. Rank hold MTRI as of Q4 2025.
- DRW Securities reported no remaining Mentari Therapeutics, Inc. Common Stock position as of Q4 2025 after selling out during the quarter.
- DRW Securities sold 3,587 Mentari Therapeutics, Inc. Common Stock shares in Q4 2025, an estimated $78.5K.
- DRW Securities first reported a position in Mentari Therapeutics, Inc. Common Stock in Q3 2025 and held it in 1 quarter.
- DRW Securities's Mentari Therapeutics, Inc. Common Stock position peaked at $78.5K in Q3 2025.
- 6 funds tracked by Wall St. Rank held Mentari Therapeutics, Inc. Common Stock as of Q4 2025.
Based on DRW Securities's 13F filing for Q4 2025, filed 12 Feb 2026.